Recent

% | $
Quotes you view appear here for quick access.

Orexigen Therapeutics, Inc. Message Board

  • ccharles792 ccharles792 Sep 9, 2012 8:24 PM Flag

    Wall Street : OREX Gets Props From Wall Street. LINK

    Another Weight Loss Drug Gets Props from Wall Street
    By Meghan Foley | More Articles
    September 08, 2012

    California-based Orexigen Therapeutics’s (NASDAQ:OREX) new weight-loss drug Contrave entered its final stage of clinical trials ahead schedule and garnered the attention of Credit Suisse, who is attempting to pick a winner from among the three new weight-loss pills set to hit markets soon.

 
OREX
3.20-0.09(-2.74%)Sep 29 4:00 PMEDT